Dow, S&P 500, Nasdaq Futures Fall As Weak Tech Earnings Trigger Selloff: INTC, IOVA, SLS, AMZN Stocks In Focus
Intel (INTC) reported Q3 sales of $16.5B, up 21% YoY, and beat earnings estimates. Weak PC demand due to memory semiconductor shortages impacted results. AMZN's earnings also dragged down chipmakers like NVDA, MU, AVGO, and AMD. U.S. consumer spending rose in September with inflation at 3.6%. Geopolitical tensions in the Strait of Hormuz pushed oil prices higher. IOVA and SLS also saw significant share price declines.
How this was made
The 30-second read
Why it matters
Earnings beat but cautious guidance for Intel drives sector weakness; biotech trial data adds volatility to small caps.
Market read
Tech earnings and memory‑price concerns triggered a multi‑stock pullback, while biotech trial news added side‑ways risk.
What to watch
Potential upside from any surprise in Intel's data‑center demand or a favorable resolution to the Middle‑East tension.
Background
The article combines Intel's earnings release with a broader tech sell‑off and updates on biotech trial outcomes.
Ticker impact
Intel reported Q3 revenue of $16.5B and EPS $0.52, beating estimates, but warned of memory shortages.
likely downside as investors price in weaker demand and memory cost pressures
Beat on earnings but forward outlook is cautious; market typically reacts negatively to demand warnings.
Amazon's Q3 earnings dragged its share lower, contributing to a broader tech sell‑off.
downward pressure as revenue miss fuels sector weakness
Amazon is a market‑weight tech stock; its decline amplified the sell‑off.
Nvidia shares slipped as the Intel‑driven tech sell‑off spread to other chipmakers.
moderate decline as investors rotate out of high‑growth chips
No company‑specific news; price move is spillover.
Micron Technologies fell alongside other semiconductor stocks after Intel's earnings.
downward as memory pricing concerns affect demand
Memory pricing headwinds impact Micron directly.
Broadcom shares declined in the wake of Intel's earnings and broader chip sell‑off.
likely dip as investors sell exposure to semiconductors
No firm‑specific catalyst; move is spillover.
Advanced Micro Devices shares were pulled down by the tech sector sell‑off triggered by Intel.
downward pressure from sector sentiment
AMD is a peer; no direct news.
Iovance Biotherapeutics stock plunged over 35% after marginal lung‑cancer trial results.
sharp downside as investors reassess pipeline value
First report of trial outcome; material for biotech valuation.
Sellas Life Sciences shares fell modestly after its Phase 3 AML trial reached a prespecified death event.
minor decline as market awaits final data
Event is a procedural step, not a result.
Market effects
Broad semiconductor sector faces pressure from memory cost concerns and Intel's demand outlook.
U.S. equity indices pressured; Asian markets opened mixed.
Tech sell‑off contributes to global risk‑off sentiment amid geopolitical tension.
Counterpoint
If memory shortages ease faster than expected, Intel and peers could rebound sharply.
Key entities
- companyIntel Corp.
Semiconductor manufacturer reporting Q3 results.
- companyAmazon.com Inc.
E‑commerce giant whose earnings contributed to the sell‑off.
- companyIovance Biotherapeutics Inc.
Biotech firm with marginal lung‑cancer trial data.
